FY2025 · ended Dec 31, 2025 · Revenue $0, -100.0% YoY · Filed Mar 23, 2026
The Cannaisseur Group, Inc. (TCRG) files with the SEC under industry code 2833, Medicinal Chemicals & Botanical Products. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $0 and a net loss of $1.8 million.
Revenue (TTM)
$0
-100.0% vs year-ago TTM
Net income (TTM)
$-1.04M
-0.4% vs year-ago TTM
Operating cash flow (TTM)
$-111,082
-0.8% vs year-ago TTM
Free cash flow
—
EPS (TTM)
$-0.02
+21.9% vs year-ago TTM
Dividend per share
None
Shares outstanding
60.46M
+21.0% vs prior year
Net cash
$-33,770
FY 2023
Operating margin
-180939.9%
FY 2024
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- TCRG (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Atlanta, GA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1879270
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
|---|---|---|---|
| Revenue | $0 | $700 | $53,130 |
| Operating income | -$1.7M | -$1.3M | -$189,900 |
| Net income | -$1.8M | -$1.3M | -$128,025 |
| Diluted EPS | -$0.03 | -$0.03 | $0.00 |
| Operating cash flow | -$127,451 | -$110,627 | -$126,074 |
| Total assets | $140 | $1,876 | $43,693 |
| Total liabilities | $235,431 | $305,576 | $136,687 |
| Stockholders' equity | -$235,291 | -$341,575 | -$130,869 |
| Cash and investments | $22 | $563 | $38,390 |
| Total debt | — | — | $72,160 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 11, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Mar 23, 2026 | Dec 31, 2025 |
| 10-Q | Quarterly report | Nov 18, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Sep 9, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 28, 2025 | Aug 28, 2025 |
All 72 The Cannaisseur Group, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.